These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 8934547)

  • 1. Detailed deletion mapping with a refined physical map of 7q31 localizes a putative tumor suppressor gene for breast cancer in the region of MET.
    Lin JC; Scherer SW; Tougas L; Traverso G; Tsui LC; Andrulis IL; Jothy S; Park M
    Oncogene; 1996 Nov; 13(9):2001-8. PubMed ID: 8934547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human breast cancer: genetic alterations in the MET gene region.
    Tougas L; Halwani F; Tremblay G; Sampalis J; Lin J; Park M; Jothy S
    Clin Invest Med; 1996 Aug; 19(4):222-30. PubMed ID: 8853570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A defined chromosome 6q fragment (at D6S310) harbors a putative tumor suppressor gene for breast cancer.
    Theile M; Seitz S; Arnold W; Jandrig B; Frege R; Schlag PM; Haensch W; Guski H; Winzer KJ; Barrett JC; Scherneck S
    Oncogene; 1996 Aug; 13(4):677-85. PubMed ID: 8761288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene.
    Zeng WR; Watson P; Lin J; Jothy S; Lidereau R; Park M; Nepveu A
    Oncogene; 1999 Mar; 18(11):2015-21. PubMed ID: 10208423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of potential tumor suppressor loci to a < 2 Mb region on chromosome 17q in human prostate cancer.
    Gao X; Zacharek A; Grignon DJ; Sakr W; Powell IJ; Porter AT; Honn KV
    Oncogene; 1995 Oct; 11(7):1241-7. PubMed ID: 7478543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers.
    Koreth J; Bakkenist CJ; McGee JO
    Oncogene; 1997 Jan; 14(4):431-7. PubMed ID: 9053840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer.
    Farrington SM; Cunningham C; Boyle SM; Wyllie AH; Dunlop MG
    Oncogene; 1996 Apr; 12(8):1803-8. PubMed ID: 8622901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers.
    Gunduz M; Ouchida M; Fukushima K; Ito S; Jitsumori Y; Nakashima T; Nagai N; Nishizaki K; Shimizu K
    Oncogene; 2002 Jun; 21(28):4462-70. PubMed ID: 12080476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
    Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
    Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene.
    Zenklusen JC; Weitzel JN; Ball HG; Conti CJ
    Oncogene; 1995 Jul; 11(2):359-63. PubMed ID: 7624150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor gene region.
    Chen T; Sahin A; Aldaz CM
    Cancer Res; 1996 Dec; 56(24):5605-9. PubMed ID: 8971163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping of a new target region of allelic loss to a 6-cM interval at 21q21 in primary breast cancers.
    Ohgaki K; Iida A; Kasumi F; Sakamoto G; Akimoto M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1998 Nov; 23(3):244-7. PubMed ID: 9790505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
    Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
    Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping an endometrial cancer tumor suppressor gene at 10q25 and development of a bacterial clone contig for the consensus deletion interval.
    Peiffer-Schneider S; Noonan FC; Mutch DG; Simpkins SB; Herzog T; Rader J; Elbendary A; Gersell DJ; Call K; Goodfellow PJ
    Genomics; 1998 Aug; 52(1):9-16. PubMed ID: 9740666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.